A0074 Phase 1/2 study of an anti-PD-L1/IL-15 variant fusion protein (SIM0237) in BCGunresponsive high-risk non-muscle-invasive bladder cancer (NMIBC)

European Urology 2026

View at publisher

Authors: D.-W. Ye, Haiqing Xu, H.L. Hu, S.S. Jiang, S.D. Zhang, Z.X. Yu, Z.W. Liu, H.T. Niu, Y. Cao, B. Shi, T. Dai, T. Wu

+4 more

J.J. Xu, R. Sun, N.T. Zhang, H.L. Sun

DOI: 10.1016/s0302-2838(26)00140-5

Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Urinary Bladder and Prostate Research